DENTSPLY (XRAY) news
Recent news
Dentsply Sirona - To permit additional EBITDA add-back for cash charges in Q3 and Q4 2026 - SEC filing
Dentsply Sirona Inc. (Nasdaq: XRAY) has announced plans to permit additional EBITDA add-backs for cash charges in the third and fourth quarters of 2026, as outlined in a recent SEC filing. This move aligns with the company’s ongoing efforts to refine its non-GAAP financial reporting and provide a…
AInvest Wire · 5d agoDentsply Sirona Inc.: Piper Sandler cuts target price to $12 from $14
Piper Sandler has revised its price target for Dentsply Sirona Inc. (XRAY), reducing it to $12 from a previous $14, according to a recent analyst note. The adjustment reflects a reassessment of the company’s near-term outlook amid evolving market dynamics and operational performance. The firm…
AInvest Wire · 5d agoDentsply Sirona: Barclays raises target price to $11 from $9
AInvest Wire · Aug 24, 2026Dentsply 2Q net sales $898M est. $890.4M
AInvest Wire · Aug 6, 2026Dentsply 2Q net sales $898M, est. $890.4M
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.